Accomplished normalization, enduring exceptionalism: Aging with HIV in the era of antiretroviral treatment.

IF 2 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Health Pub Date : 2026-07-29 DOI:10.1177/13634593261469818
Tony Sandset
{"title":"Accomplished normalization, enduring exceptionalism: Aging with HIV in the era of antiretroviral treatment.","authors":"Tony Sandset","doi":"10.1177/13634593261469818","DOIUrl":null,"url":null,"abstract":"<p><p>This article examines how adults aged 50 years and older living with HIV in Norway negotiate the contemporary shift from AIDS exceptionalism to biomedical normalization, and what this reveal about the endurance of exceptionalism \"by other means.\" Drawing on 21 semi-structured life-course interviews with people living with HIV, including long-term survivors diagnosed prior to combination ART in 1996, and analyzed through reflexive thematic analysis, the study identifies three patterned meanings. First, participants described \"accomplished normalization\": HIV was narrated as clinically stable and increasingly comparable to other age-related conditions, supported by simplified ART routines and routinized follow-up care. Second, normalization was \"disrupted\" and at times actively contested, through stigma encounters, disclosure dilemmas, and especially sexuality and intimacy reactivated HIV as exceptional despite biomedical control. Third, participants articulated \"discursive undetectability\": viral suppression was experienced as a biomedical achievement, yet many perceived declining public and professional knowledge about contemporary HIV, producing renewed fear, misrecognition, and incentives to conceal serostatus. The findings suggest that later-life HIV is characterized by an ambivalent coexistence of clinical normalization and social exceptionalism, and that meaningful normalization requires sustained public education and recognition alongside pharmaceutical efficacy.</p>","PeriodicalId":12944,"journal":{"name":"Health","volume":" ","pages":"13634593261469818"},"PeriodicalIF":2.0000,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13634593261469818","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

This article examines how adults aged 50 years and older living with HIV in Norway negotiate the contemporary shift from AIDS exceptionalism to biomedical normalization, and what this reveal about the endurance of exceptionalism "by other means." Drawing on 21 semi-structured life-course interviews with people living with HIV, including long-term survivors diagnosed prior to combination ART in 1996, and analyzed through reflexive thematic analysis, the study identifies three patterned meanings. First, participants described "accomplished normalization": HIV was narrated as clinically stable and increasingly comparable to other age-related conditions, supported by simplified ART routines and routinized follow-up care. Second, normalization was "disrupted" and at times actively contested, through stigma encounters, disclosure dilemmas, and especially sexuality and intimacy reactivated HIV as exceptional despite biomedical control. Third, participants articulated "discursive undetectability": viral suppression was experienced as a biomedical achievement, yet many perceived declining public and professional knowledge about contemporary HIV, producing renewed fear, misrecognition, and incentives to conceal serostatus. The findings suggest that later-life HIV is characterized by an ambivalent coexistence of clinical normalization and social exceptionalism, and that meaningful normalization requires sustained public education and recognition alongside pharmaceutical efficacy.

完成正常化,持久例外:抗逆转录病毒治疗时代的艾滋病患者。
本文考察了挪威50岁及以上的艾滋病毒感染者如何适应从艾滋病例外论到生物医学正常化的当代转变,以及这揭示了“通过其他方式”的例外论的持久性。通过对艾滋病毒感染者进行21次半结构化的生命历程访谈,包括1996年在联合抗逆转录病毒治疗之前被诊断出的长期幸存者,并通过反身性主题分析进行分析,该研究确定了三种模式意义。首先,参与者描述了“完成正常化”:艾滋病毒被描述为临床稳定,并且在简化的抗逆转录病毒治疗程序和常规随访护理的支持下,与其他与年龄相关的疾病越来越相似。其次,正常化被“打乱”,有时还会受到积极的质疑,通过污名化遭遇、披露困境,尤其是性行为和亲密关系,尽管有生物医学控制,但艾滋病毒仍被重新激活。第三,参与者阐述了“话语不可检测性”:病毒抑制被视为一项生物医学成就,但许多人认为公众和专业人士对当代艾滋病毒的认识正在下降,从而产生了新的恐惧、误解和隐瞒血清状态的动机。研究结果表明,老年艾滋病毒的特点是临床正常化和社会例外主义的矛盾共存,而有意义的正常化需要持续的公众教育和认可,以及药物疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Health
Health Multiple-
CiteScore
4.90
自引率
0.00%
发文量
0
期刊介绍: Health: is published four times per year and attempts in each number to offer a mix of articles that inform or that provoke debate. The readership of the journal is wide and drawn from different disciplines and from workers both inside and outside the health care professions. Widely abstracted, Health: ensures authors an extensive and informed readership for their work. It also seeks to offer authors as short a delay as possible between submission and publication. Most articles are reviewed within 4-6 weeks of submission and those accepted are published within a year of that decision.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书